Transplants for Hemophilia

Andrew Gómez-Vargas, Gonzalo Hortelano

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Current research focuses on the task of replacing the function of a deficient gene due to inborn defects such as hemophilia. The ability of hematopoietic cells (HSCs) to permanently reconstitute the hematopoietic and the immune system after transplantation makes these cells a desirable tool for gene therapy approaches. Therefore, HSCs are considered a suitable target cell population in gene therapy for genetic disorders susceptible to bone-marrow transplantation. In the treatment of hemophilia, successful stem-cell transplants have to rely on the ability of stem cells to survive for a long time in the appropriate conditions while expressing the therapeutic product. Recent experiments have shown the importance of the immune response in mediating stem cell graft rejection, demonstrating that cell transplantation for hemophilia is not a simple task. Adult bone marrow cells can be further divided into undifferentiated parenchymal cells, generally referred to as stem cells, and partially differentiated mesenchymal stromal cells (which play a supportive role for the former).

Original languageEnglish
Title of host publicationCellular Transplantation
PublisherElsevier
Pages187-203
Number of pages17
ISBN (Print)9780123694157
DOIs
Publication statusPublished - 2007
Externally publishedYes

Fingerprint

Transplants
Hemophilia A
Stem cells
Stem Cells
Gene therapy
Cell Transplantation
Genetic Therapy
Bone
Cells
Transplantation (surgical)
Hematopoietic System
Inborn Genetic Diseases
Health Services Needs and Demand
Immune system
Graft Rejection
Bone Marrow Transplantation
Mesenchymal Stromal Cells
Grafts
Bone Marrow Cells
Immune System

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Gómez-Vargas, A., & Hortelano, G. (2007). Transplants for Hemophilia. In Cellular Transplantation (pp. 187-203). Elsevier. https://doi.org/10.1016/B978-012369415-7/50011-9

Transplants for Hemophilia. / Gómez-Vargas, Andrew; Hortelano, Gonzalo.

Cellular Transplantation. Elsevier, 2007. p. 187-203.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gómez-Vargas, A & Hortelano, G 2007, Transplants for Hemophilia. in Cellular Transplantation. Elsevier, pp. 187-203. https://doi.org/10.1016/B978-012369415-7/50011-9
Gómez-Vargas A, Hortelano G. Transplants for Hemophilia. In Cellular Transplantation. Elsevier. 2007. p. 187-203 https://doi.org/10.1016/B978-012369415-7/50011-9
Gómez-Vargas, Andrew ; Hortelano, Gonzalo. / Transplants for Hemophilia. Cellular Transplantation. Elsevier, 2007. pp. 187-203
@inbook{b815a4a2c22a46c3b69169be400b4d3c,
title = "Transplants for Hemophilia",
abstract = "Current research focuses on the task of replacing the function of a deficient gene due to inborn defects such as hemophilia. The ability of hematopoietic cells (HSCs) to permanently reconstitute the hematopoietic and the immune system after transplantation makes these cells a desirable tool for gene therapy approaches. Therefore, HSCs are considered a suitable target cell population in gene therapy for genetic disorders susceptible to bone-marrow transplantation. In the treatment of hemophilia, successful stem-cell transplants have to rely on the ability of stem cells to survive for a long time in the appropriate conditions while expressing the therapeutic product. Recent experiments have shown the importance of the immune response in mediating stem cell graft rejection, demonstrating that cell transplantation for hemophilia is not a simple task. Adult bone marrow cells can be further divided into undifferentiated parenchymal cells, generally referred to as stem cells, and partially differentiated mesenchymal stromal cells (which play a supportive role for the former).",
author = "Andrew G{\'o}mez-Vargas and Gonzalo Hortelano",
year = "2007",
doi = "10.1016/B978-012369415-7/50011-9",
language = "English",
isbn = "9780123694157",
pages = "187--203",
booktitle = "Cellular Transplantation",
publisher = "Elsevier",
address = "Netherlands",

}

TY - CHAP

T1 - Transplants for Hemophilia

AU - Gómez-Vargas, Andrew

AU - Hortelano, Gonzalo

PY - 2007

Y1 - 2007

N2 - Current research focuses on the task of replacing the function of a deficient gene due to inborn defects such as hemophilia. The ability of hematopoietic cells (HSCs) to permanently reconstitute the hematopoietic and the immune system after transplantation makes these cells a desirable tool for gene therapy approaches. Therefore, HSCs are considered a suitable target cell population in gene therapy for genetic disorders susceptible to bone-marrow transplantation. In the treatment of hemophilia, successful stem-cell transplants have to rely on the ability of stem cells to survive for a long time in the appropriate conditions while expressing the therapeutic product. Recent experiments have shown the importance of the immune response in mediating stem cell graft rejection, demonstrating that cell transplantation for hemophilia is not a simple task. Adult bone marrow cells can be further divided into undifferentiated parenchymal cells, generally referred to as stem cells, and partially differentiated mesenchymal stromal cells (which play a supportive role for the former).

AB - Current research focuses on the task of replacing the function of a deficient gene due to inborn defects such as hemophilia. The ability of hematopoietic cells (HSCs) to permanently reconstitute the hematopoietic and the immune system after transplantation makes these cells a desirable tool for gene therapy approaches. Therefore, HSCs are considered a suitable target cell population in gene therapy for genetic disorders susceptible to bone-marrow transplantation. In the treatment of hemophilia, successful stem-cell transplants have to rely on the ability of stem cells to survive for a long time in the appropriate conditions while expressing the therapeutic product. Recent experiments have shown the importance of the immune response in mediating stem cell graft rejection, demonstrating that cell transplantation for hemophilia is not a simple task. Adult bone marrow cells can be further divided into undifferentiated parenchymal cells, generally referred to as stem cells, and partially differentiated mesenchymal stromal cells (which play a supportive role for the former).

UR - http://www.scopus.com/inward/record.url?scp=84882550413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882550413&partnerID=8YFLogxK

U2 - 10.1016/B978-012369415-7/50011-9

DO - 10.1016/B978-012369415-7/50011-9

M3 - Chapter

SN - 9780123694157

SP - 187

EP - 203

BT - Cellular Transplantation

PB - Elsevier

ER -